PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.21
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
3.59
P/S less than half of CRON.TO's 22.08. Joel Greenblatt would verify if margins support this discount.
0.24
P/B less than half of CRON.TO's 0.68. David Dodd would verify if asset quality justifies this discount.
-33.09
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.
-115.89
Negative operating cash flow while CRON.TO shows P/OCF of 262.12. Joel Greenblatt would examine operational improvement potential.
0.24
Fair value ratio less than half of CRON.TO's 0.68. David Dodd would verify if competitive position justifies this discount.
-118.24%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-3.02%
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.